Key result
Maternal serum biomarkers such as PlGF, sFlt-1, and sEng, when used in combination with other clinical predictors, show promise for the early prediction and diagnosis of preeclampsia.
Why the study?
Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality with an unknown etiology, creating an urgent need for first-trimester markers for prediction.
Combinations of maternal serum biomarkers, particularly angiogenic and anti-angiogenic factors, along with clinical risk factors, are necessary for the effective early prediction of preeclampsia.
Answers are grounded in this paper and cite their sources.
May aid early preeclampsia prediction via combined biomarkers and clinical factors; leaves open prospective validation before practice change.
Background: Preeclampsia (PE) is a pregnancy specific disorder, characterized by new onset of hypertension and proteinuria after 20 weeks of gestation. It is one of the leading causes of maternal and perinatal morbidity and mortality. The etiology of the disease process in not known. There is an urgent need for a 1st trimester marker for the prediction of preeclampsia. Recent studies have reported that this disease originate from abnormal placentation and maternal endothelial dysfunction. The intense research in this arena has unveiled some important serum biomarkers which play an important role in placentation. These markers include angiogenic and antiangiogenic molecules. However, these markers when they used alone are not effective for the prediction of preeclampsia, but in combination may help in predicting women who are likely to develop preeclampsia. This review summarizes the various maternal serum biomarkers available and utility in predicting preeclampsia.
No takes yet. Share an insight, caveat, or question.
Gandham et al. (2019) conducted a review in Preeclampsia. Maternal serum biomarkers (e.g., PlGF, sFlt-1, sEng) was evaluated. Maternal serum biomarkers such as PlGF, sFlt-1, and sEng, when used in combination with other clinical predictors, show promise for the early prediction and diagnosis of preeclampsia.
Synapse has enriched 10 related papers. Consider them for comparative context: